Our Global Organisation

Boehringer Ingelheim is a research driven group of companies dedicated to researching, developing, manufacturing and marketing pharmaceuticals that improve health and quality of life.

Our business consists of Prescription Medicines, Consumer Healthcare, Biopharmaceuticals and Animal Health. We focus on the production of innovative drugs and treatments that represent the major therapeutic advances.

Excellence in innovation and technology guides our actions in all areas. Our products have long been highly successful in the treatment of respiratory, cardiovascular, central nervous system and virological disorders. In addition to offering valuable treatments for cancer and AIDS, we have intensified our research into the immune system, viral disease and cancer.

Boehringer Ingelheim currently has 42,000 employees, and 145 affiliates in 50 countries around the globe.

Our headquarters is at Ingelheim, the German town where the company was founded in 1885.

For more information please visit the Global Activities section on our corporate website.